IFI6 and neoplasm: IFI6 also serves as a potential molecular mechanism that tumor cells might employ to resist chemotherapeutic drugs, including cycloheximide (CHX) or 5-fluorouracil (5-FU) because its expression is potently enhanced in multidrug-resistant malignant cells and attenuates apoptosis following anti-tumor therapy [10].